High circulating concentrations of lipoproteins have been shown to modify the cytokine response and reduce mortality after endotoxin or live bacterial challenge. Sepsis, however, is more complex than endotoxemia, and it is not clear whether elevated plasma lipoproteins will be protective. Previous studies have shown that the low-density-lipoprotein receptor deficient (LDLR -/-) mice with increased circulating LDL are protected against the lethal effects of endotoxemia and Gramnegative infection. We evaluated whether the LDLR -/mice would be protected against the effects of sepsis induced by cecal ligation and puncture (CLP). Mortality was greater in LDLR -/mice than in control C57Bl/6J mice. At 120 h after inducing sepsis, 20% of the control mice survived whereas none of the LDLR -/mice were alive. Prior to inducing sepsis, serum concentrations of amyloid A protein and lipopolysaccharide binding protein (LBP) were significantly elevated in the LDLR -/mice in comparison to the C57Bl/6J mice. Protein expression of sCD14 was also greater in the serum from the LDLR -/mice than the C57Bl/6J mice. The elevated serum concentrations of LBP and CD14 were not associated with increases in the levels of liver CD14 mRNA and LBP mRNA. After inducing sepsis, serum concentration of interleukin (IL)-1b was also significantly higher in LDLR -/mice than in the control C57Bl/6J mice. These findings indicate that the LDLR -/mice were more susceptible to the lethal effects of sepsis induced by CLP. The LDLR -/mice also had higher serum concentrations of baseline, acute phase response proteins, SAA and LBP, and increased production of IL-1b in response to CLP.
INTRODUCTION
Hyperlipoproteinemia is thought to be protective against the lethal effects of Gram-negative infection and endotoxemia. Several laboratories have demonstrated that infusions of chylomicrons, very-low-density lipoproteins (VLDL), a triglyceride-rich lipid emulsion (Intralipid), or reconstituted high-density lipoproteins (HDL) protect against the lethality of endotoxemia and challenge of live bacteria. [1] [2] [3] [4] [5] Endogenous HDL has also been shown to improve survival in endotoxin-challenged mice over-expressing HDL. 5 Low density lipoprotein receptor-deficient (LDLR -/-) mice have extreme elevations in blood levels of cholesterol and triglycerides that are due to increases in LDL and intermediate density lipoproteins. The hypercholesterolemia in the LDLR -/mice is reported to be associated with protection from the lethal effects of acute endotoxemia and infection with Klebsiella pneumoniae. 6 In septic patients, circulating lipopolysaccharide (LPS) was found to bind predominantly to LDL and VLDL, which indicates a potential role for these lipoproteins in the detoxification of LPS. 7 In contrast to LDLR -/mice, apolipoprotein (apo) E -/-mice, with hypercholesterolemia due to increased VLDL, had a poor survival rate in response to endotoxin-challenge, 8, 9 and infection with Listeria monocytogenes. 10 Since both strains of mice have elevated plasma levels of cholesterol, it has been hypothesized that the impaired survival in apo E -/was due to lack of apo E. 9, 10 Recent studies have demonstrated that administering chylomicrons supplemented with apo E or administering apo E alone can reduce the uptake of labeled LPS by splenic macrophages and Kupffer cells, LPS-induced cytokine levels, and mortality due to endotoxin challenge. 11, 12 The complex role played by apolipoproteins and lipoproteins is far from being understood in bacterial infections. It is not clear why LDLR -/mice are protected against infections with Klebsiella while being highly susceptible to Candida infections. 13 Since clinical sepsis is different than receiving a bolus dose of bacteria or endotoxin, we investigated whether LDLR -/mice would be protected during sepsis induced by cecal ligation and puncture (CLP). CLP is considered a more clinically relevant model of sepsis than endotoxemia in that it produces the pathological conditions associated with human sepsis. 14 The CLP model produces both Gram-negative and Grampositive organisms that are continually released over a long period of time, which is similar to human sepsis. We also evaluated the acute phase status in the LDLR -/mice by measuring serum amyloid A (SAA) protein, lipopolysaccharide-binding protein (LBP), and albumin.
MATERIALS AND METHODS

Animals
Ten-week-old, male C57Bl/6J and LDLR -/mice were used in these studies. LDLR -/mice and C57Bl/6J mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA). C57Bl/6J mice were used as control mice because the LDLR -/mice were generated from the C57Bl/6J background. All mice were allowed free access to a standard rodent diet (#5001, Purina, St Louis, MO, USA). This study was conducted in accordance with the National Institutes of Health Guidelines and approved by the Animal Care and Use Committee of Thomas Jefferson University.
Protocol
Sepsis was induced by CLP in male C57Bl/6J and LDLR -/mice. CLP is a well-described method for inducing experimental sepsis; sepsis results from both Gram-negative and Gram-positive organisms that have been characterized. 15 Mice were anesthetized with isoflorane. After making a 1.5 cm laparotomy incision, the cecum was isolated and ligated with 5-0 sutures just below the ileocecal valve and punctured twice with a 27gauge needle. The abdomen was closed in two layers using 5-0 sutures and the mice were resuscitated by s.c. injection of normal saline (3 ml/100g body weight). Control mice in this study underwent laparotomy, manipulation of the cecum, and resuscitation. In a preliminary study, we observed that there were no differences in mortality between untreated control mice and sham control mice. Based upon this observation, we used sham controls in this study.
Blood (250 ml) was obtained from the retroorbital plexus 24 h prior to and 24 h after CLP. Livers were removed 24 h after CLP.
Serum total cholesterol and triglycerides
Serum triglyceride concentration was measured by coupled enzyme reactions catalyzed by lipoprotein lipase, glycerol kinase, glycerol phosphate oxidase, and peroxidase, which led to the formation of a quinoneimine dye. The color intensity produced was determined at an absorbance of 540 nm, which is directly proportional to the triglyceride concentration (GPO-Trinder Kit: Sigma Chemical Co., St Louis, MO, USA). Serum cholesterol was also measured by coupled enzyme reactions involving cholesterol esterase, cholesterol oxidase, and peroxidase leading to the formation of a quinoneimine dye. The color intensity produced was determined at an absorbance of 500 nm, which is directly proportional to the cholesterol concentration (Cholesterol kit: Sigma Chemical Co.).
Serum tumor necrosis factor-a, interleukin-1b, serum amyloid A protein, albumin, and lipopolysaccharide binding protein
SAA protein, LBP, and albumin were measured prior to CLP. Serum tumor necrosis factor (TNF)-a and interleukin (IL) 1b were measured at 5 h and 24 h, respectively after CLP. The concentrations of serum TNF-a, IL-1b, and SAA protein were determined by using commercial ELISA kits (BioSource International, Camarillo, CA, USA). Serum LBP concentrations were determined by ELISA as described in detail previously. 16 The ELISA test kits used for TNF-a, IL-1b, LBP, and SAA protein were based upon the sandwich principle; antigen-specific biotin conjugate is added to wells to bind captured protein, then a biotin-streptavidin-horseradish peroxidase is added to detect the amount of specific protein. Serum albumin was measured using a colorimetric procedure in which bromocresol green binds quantitatively to albumin and the intensity of the color is proportional to the amount of albumin in the sample (Albumin kit from Sigma Chemical Co.).
Western analysis of soluble CD14 (sCD14)
Plasma was electrophoresed on a 12% SDS-polyacrylamide gel and transferred to nitrocellulose membrane. The blots were blocked with PBS containing 5% powdered milk for 1 h at room temperature, and incubated with an anti-mouse CD14 rat monoclonal antibody (Pharmingen, San Diego, CA, USA). The membranes were washed 3 times with PBS containing 0.1% Tween-20 and 5% powdered milk and incubated with horseradish peroxidase conjugated to rabbit anti-rat IgG antibody (Sigma Chemical Co.). Bands were visualized by an enhanced chemiluminescence technique (Amersham).
Extraction and quantification of mRNA levels by ribonuclease protection assays
Total RNA was extracted from the liver using the acid guanidium-phenol-chloroform extraction method described by Chomczynski and Sacchi. 17 The plasmid for synthesis of mouse CD14 probe was created by synthesis of a cDNA using total RNA from mouse lung and oligo (dT) followed by cloning. CD14 cDNA was amplified using a forward primer (5¢-GCCAGATTGGTCCAGCGC-3¢) and a reverse primer (5¢-AAGAGGCGATCTCCTAGG-3¢). These oligonucleotides correspond to nucleotide sequences 146-163 and 1126-1109 of mouse CD14, respectively; 18 GenBank accession number X13333. This fragment of CD14 cDNA was digested with Pvu II and Sac I and cloned into plasmid pBluescript II SK + using Eco RV and Sac I sites and subsequently used for ribonuclease protection assays. This plasmid, digested with Xho I to make a 339base radiolabeled antisense probe, contained a 295-base protected fragment.
The plasmid for synthesis of mouse LPS-binding protein (LBP) probes was created by synthesis of a cDNA using total RNA from mouse liver and oligo (dT) followed by cloning. LBP cDNA was amplified using a forward primer (5¢-TGACCTCTGACCTGCAGCC-3¢) and a reverse primer (5¢-GAAGGGACGGAAGGCCTTG-3¢). These oligonucleotides correspond to nucleotide sequences 741-756 and 1099-1081 of mouse LBP, respectively; 19 GenBank accession number X99347. This fragment of LBP cDNA was digested with Pst I and Stu I and cloned into plasmid pBluescript II SK + using Eco RV and Pst I sites for use in ribonuclease protection assays. This plasmid was digested with Xba I to make a 411-base radiolabeled antisense probe that contained a 333-base protected fragment.
The plasmid for synthesis of mouse 18S probe was created by synthesis of a cDNA using total RNA from mouse lung and a reverse primer followed by cloning. 18S cDNA was amplified using a forward primer (5¢-AACCAACCCGGTGAGCTC-3¢) and a reverse primer (5¢-CTAGCTGCGGTATCCAGG-3¢). These oligonucleotides correspond to nucleotide sequences 233-251 and 860-843 of mouse 18S rRNA, respectively; 20 GenBank accession number is X00686. This fragment of cDNA for 18S rRNA was digested with Pst I and Xba I and cloned into plasmid pBluescript II SK + for use in ribonuclease protection assays. This plasmid, digested with Xba I to make a 435-base radiolabeled antisense probe, contained a 372base protected fragment. Mouse 18S ribosomal RNA antisense probe was used to evaluate total RNA, which in turn was used for expression analysis.
All constructs used in this work were verified by sequencing the insert in the plasmid. These sequences were found to be 100% identical to the published sequences.
Synthesis of radiolabeled probes for the ribonuclease protection assay was carried out according to the Boehringer Mannheim protocol using T7 or T3 RNA polymerase (Boehringer Mannheim GmbH, Germany) and [ 32 P]-UTP (800 Cu/mmol; NEN Life Science Products, Arlington, IL, USA). For ribonuclease protection assays, aqueous solutions of total RNA were dried under vacuum and dissolved in 25 ml of 80% formamide hybridization buffer containing labeled probes. Samples were pre-incubated for 5 min at 85°C and then incubated for 16 h at 45°C. The extracted, protected probe fragments were run on a 6% polyacrylamide sequencing gel in 1x Tris-borate-EDTA buffer for 2 h at 50 mA. The gel was then dried and exposed to X-ray film (Hyperfilm MP, Amersham) at -70°C. Expression of mRNA was quantified using ImageQuant software (Molecular Dynamics, Sunnyvale, CA, USA). Intensity of each mRNA band was normalized for the 18S ribosomal RNA level.
Statistical analysis
Kaplan-Meier plots were constructed and the differences in survival between the LDLR -/and C57Bl/6J mice were analyzed by the exact log-rank test. Differences in concentrations of TNF-a, IL-1b, LBP, SAA, albumin, LBP mRNA and CD14 mRNA were analyzed by two-way analysis of variance. When significant differences (P £ 0.05) were found using ANOVA, group means were compared using Bonferroni's correction for the Student's t-test.
RESULTS
Serum total cholesterol and triglyceride
Baseline concentrations of serum total cholesterol were significantly higher in the LDLR -/mice (2.0 ± 0.15 mg/ml; n = 8) as compared with the C57Bl/6J mice (0.86 ± 0.03 mg/ml; n = 8; P < 0.05). Serum triglycerides were also increased significantly in the LDLR -/mice (1.0 ± 0.12 mg/ml; n = 8) compared with the C57Bl/6J mice (0.68 ± 0.07 mg/ml; n = 8; P < 0.05). Table 1 shows that the LDLR -/mice exhibited a 92% increase in the serum concentration of LBP compared to the C57Bl/6J mice (P < 0.05). The protein expression of sCD14 in the serum was also greater in the LDLR -/mice than in the C57Bl/6J mice (Fig. 1) . The concentration of SAA protein in the LDLR -/mice was 38% higher than the C57Bl/6J mice (Table 1) while serum albumin concentrations were lower. These findings indicate that LDLR -/mice are in an acute phase response in a non-septic state.
Basal circulating LBP, sCD14, serum amyloid A protein, and albumin
Survival study
At 72 h after CLP, 46% of the C57Bl/6J mice and 33% of the LDLR -/were alive (Fig. 2) . After 120 h, none of the LDLR -/mice were alive whereas 20% of the C57Bl/6J mice survived. The log-rank analysis demonstrated that survival was significantly different in the LDLR -/mice (P = 0.05) compared with the C57Bl/6J mice.
Serum cytokines
Cytokines have been implicated in the pathogenesis of septic shock. As an example, Table 2 shows that serum TNF-a concentrations were higher in the LDLR -/mice at 5 h after CLP than the C57Bl/6 mice. At 24 h after CLP, the serum IL-1b concentration was significantly increased in the LDLR -/-(46%) mice compared with the C57Bl/6J mice. TNF-a and IL-1b were not detected in the serum prior to CLP.
Expression of CD14 mRNA and lipopolysaccharide binding protein mRNA
The levels of mRNA were determined by ribonuclease protection assay and quantified using ImageQuant software. The linearity of the assay was verified by measuring the density units of different concentrations of total liver RNA. Figure 3 shows that for CD14 and LBP there was a relatively linear relationship between densitometric units per sample and the amount of RNA. In all assays, a constant volume of sample was used. Thus, the samples were evaluated in the linear portion of the curve. To determine the contribution of the liver to the increased circulating levels of CD14 and LBP, we examine the expression of CD14 and LBP mRNA. 18S ribosomal RNA levels were used as controls of RNA loading in electrophoresis gels. Levels of this rRNA were similar in the liver of both groups studied (Figs 4 & 5) . Although the protein expression of plasma CD14 was increased in the non-septic LDLR -/mice (Fig. 1) , the levels of CD14 mRNA in the livers were not increased in these mice. The level of CD14 mRNA was higher in the livers from the mice after CLP than those without CLP. After CLP, the expression of CD14 mRNA increased more in the livers from the LDLR -/mice than in the livers from the C57Bl/6J mice (Fig. 4) . As shown in Figure 5 , the increased concentrations of LBP in the serum of the LDLR -/mice did not appear to be due to increased liver synthesis because LBP mRNA levels were not elevated in the livers from these mice. After CLP, LBP mRNA expression increased in the livers from both groups; there were no significant difference between the groups.
DISCUSSION
Previous reports have shown that increased concentrations of circulating lipoproteins are protective against a Hyperlipoproteinemic LDL receptor-deficient mice: susceptibility to sepsis 345 Fig. 3 . Validation of the linearity of the ribonuclease protection assay. The concentrations of CD14 mRNA and LBP mRNA were determined in total liver mRNA. ImageQuant software was used to quantitate the levels of mRNA and the results were plotted as densitometric units as a function of increasing amounts of mRNA. Values are means ± SD for n = 3. bolus infusion of endotoxin or bacteria. [1] [2] [3] [4] [5] In this study, we have demonstrated that the LDLR -/mice with increased circulating LDL and IDL were not protected against the lethal effects of sepsis induced by CLP.
In most animal models, the circulating concentrations of SAA protein and LBP increase dramatically after infection or endotoxemia. The plasma concentrations of LBP and SAA protein in mice were reported to increase 8-and 20fold, respectively, after a bolus dose of LPS. 21, 22 Basal concentrations of these proteins are generally very low in those models. In contrast, the basal levels of LBP, CD14, and SAA protein were significantly higher in LDLR -/mice than in the control mice. The increases in circulating acute phase proteins in the LDLR -/mice may lead to an exaggerated pro-inflammatory response in response to sepsis whereas it may not impair their ability to tolerate endotoxemia or bacteremia. 6 Since the liver is a source of circulating CD14 and LBP, 23, 24 we measured the mRNA levels for these proteins.
The increased serum LBP in the LDLR -/mice was not associated with increased liver LBP mRNA. Moreover, the increased circulating sCD14 in the LDLR -/mice were not consistent with increased mRNA levels in the liver. The increased circulating LBP and sCD14 may be due to decreased protein turnover or increased synthesis of LBP and CD14 in organs other than the liver. During sepsis, synthesis of LBP and CD14 was elevated in the kidney, lung, circulating monocytes, and liver. 25 The LDLR -/mice were not protected against sepsis induced by CLP even though the elevated plasma lipoproteins are thought to neutralize the endotoxin. An earlier report showed that the elevated plasma cholesterol in LDLR -/mice improved survival by impairing the cytokine response to a bolus dose of endotoxin or a bolus dose of K. pneumoniae bacteria. 6 However, models of acute endotoxemia and bacteremia induced by a bolus doses may not be appropriate clinical models. Unlike the single bolus dose of endotoxin or bacteria, sepsis induced by CLP is characterized by a continual release of bacteria resulting in constant, lower levels of endotoxin and cytokines. This model is similar to human sepsis. 14, 26, 27 Hyperlipoproteinemia may not be protective during intra-abdominal sepsis because the continual flow of bacteria may overwhelm the neutralization capacity of the blood. Intra-abdominal sepsis also develops from both Gram-negative and Gram-positive bacteria. 15 Some of these bacteria (e.g. Staphylococcus aureus) and the yeast Candida albicans have been shown to grow better in a lipid environment. 28 Survival of LDLR -/mice in response to C. albicans infection was impaired, which appeared to be due to increased growth of the micro-organism in the organs rather than acute cytokinemia. 13 Additionally, Gram-positive organisms involve different Toll receptors and possibly different pathways than Gram-negative organisms. 29 The increased susceptibility of the LDLR -/mice to sepsis induced by CLP may also be due to factors inherent in the transgenic mice and not directly related to the presence of high circulating LDL and IDL. Inducing hyperlipidemia in rats with lipoprotein infusions protected them against sepsis induced by CLP. 4 This finding suggests that the poor survival of LDLR -/mice in response to CLP may be due to other abnormalities, which may or may not be related to the prolonged hyperlipoproteinemia.
The high mortality during sepsis results from organ failure. The increased CD14 mRNA in livers from septic LDLR -/mice suggests that local production of this protein is elevated. The early rise in tissue levels of CD14 and LBP may serve to prevent illness. However, a prolonged rise in these acute phase proteins in the organs could augment and prolong the response to CLP, which would eventually lead to organ failure and death.
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